BPG is committed to discovery and dissemination of knowledge
Retrospective Study
Copyright: ©Author(s) 2026.
World J Gastrointest Oncol. Jul 15, 2026; 18(7): 120437
Published online Jul 15, 2026. doi: 10.4251/wjgo.120437
Table 1 Baseline characteristic comparison (development vs temporally independent test cohort), mean ± SD/n (%)
Characteristics
Development cohort (n = 680)
Independent test cohort (n = 170)
Statistic
P value
Age (years)62.56 ± 10.7063.24 ± 11.440.9180.359
Sex (male/female)375/30595/750.0300.863
BMI (kg/m2)23.5 ± 3.223.8 ± 3.4t = 1.060.291
Ileus0.8030.370
Yes68 (10.0)21 (12.4)
No612 (90.0)149 (87.6)
Tumor location
Colon cancer425 (62.5)105 (61.8)χ2 test0.861
Rectal cancer255 (37.5)65 (38.2)
Maximum tumor diameter (cm)4.2 ± 1.84.3 ± 1.7t-test0.512
Preoperative CEA (≥ 5 ng/mL)306 (45.0)77 (45.3)0.0050.945
T-staging
T185 (12.5)22 (12.9)0.0510.997
T2170 (25.0)43 (25.3)
T3306 (45.0)75 (44.1)
T4119 (17.5)30 (17.6)
N-staging
N0374 (55.0)93 (54.7)0.0200.995
N1204 (30.0)51 (30.0)
N2102 (15.0)26 (15.3)
Pathological differentiation0.2030.652
High/moderate differentiation476 (70.0)122 (71.8)
Poor differentiation/mucinous adenocarcinoma204 (30.0)48 (28.2)
Image quality score
3 points (acceptable)204 (30.0)51 (30.0)0.0001.000
4 points (good)340 (50.0)85 (50.0)
5 points (excellent)136 (20.0)34 (20.0)
Table 2 Diagnostic performance of the prediction model for the development and independent test cohorts

AUC (95%CI)
Sensitivity
Specificity
Accuracy
Weighted Kappa (95%CI)
T staging
T1 vs T2-4Development cohort0.868 (0.747-0.988)0.7690.9660.941
Independent test cohort0.898 (0.809-0.959)0.8640.9320.925
T2 vs othersDevelopment cohort0.934 (0.867-1.000)0.8800.9870.961
Independent test cohort0.899 (0.832-0.952)0.8600.9370.917
T3 vs othersDevelopment cohort0.958 (0.918-0.999)0.9350.9820.961
Independent test cohort0.896 (0.855-0.946)0.8130.9790.910
T4 vs othersDevelopment cohort0.927 (0.849-1.000)0.8890.9640.951
Independent test cohort0.949 (0.888-0.982)0.9330.9640.959
TotalDevelopment cohort0.888 (0.802-0.974)
Development cohort0.888 (0.802-0.974)0.862 (0.821-0.903)
Independent test cohort0.907 (0.862-0.954)0.841 (0.792-0.890)
N staging
N0 vs othersDevelopment cohort0.868 (0.801-0.935)0.9110.8260.873
Independent test cohort0.917 (0.807-1.000)1.0000.8330.923
N1 vs othersDevelopment cohort0.847 (0.767-0.927)0.8060.8870.863
Independent test cohort0.915 (0.850-0.980)0.8301.0000.946
N2 vs othersDevelopment cohort0.955 (0.888-1.000)0.9330.9770.971
Independent test cohort0.900 (0.816-0.984)0.8001.0000.966
TotalDevelopment cohort0.874 (0.828-0.920)
Development cohort0.874 (0.828-0.920)0.874 (0.835-0.913)
Independent test cohort0.912 (0.867-0.956)0.858 (0.811-0.905)
Table 3 Ablation experimental results on the independent test set
Model configuration
T-stage AUC
N-stage AUC
T-staging accuracy
N-staging accuracy
Weighted Kappa coefficient
Single-path backbone network0.8520.8610.8350.8710.784
Removal of dual-path fusion0.8730.8790.8590.8910.812
Removal of cross-attention mechanism0.8810.8860.8640.9020.828
Removal of feature pyramid network0.8920.8980.8760.9180.846
Complete model (the method proposed herein)0.9070.9120.8980.9490.883
Table 4 Confusion matrices (T staging)
Gold standard
T1 (n = 22)
T2 (n = 43)
T3 (n = 75)
T4 (n = 30)
Total
Prediction model
T11954129
T20377145
T32061063
T41132833
Total22437530170
Accuracy (%)86.486.081.393.3
Table 5 Confusion matrices (N staging)
Gold standard
N0 (n = 93)
N1 (n = 51)
N2 (n = 26)
Total
Prediction model
N09396108
N1042042
N2002020
Total935126170
Accuracy (%)100.082.476.9
Table 6 Diagnostic performance comparison (prediction model vs physician group) on the independent test set
Comparison item
Prediction model
Physician group
P value
T-staging
Accuracy0.8980.8190.043
AUC (95%CI)0.907 (0.862-0.954)0.817 (0.757-0.873)0.016
N-staging
Accuracy0.9490.8390.038
AUC (95%CI)0.912 (0.867-0.956)0.765 (0.680-0.857)0.001


Write to the Help Desk